SI
SI
Advertise on SI

 Biotech / Medical: NPSP NPS Pharmaceutical
Posts: 348 | Member SubjectMarks: 47 | No Bans

Add SubjectMark | Hide Original Post | Show Chart | Poster Summary | Share This Board

Moderated By: Jim Langdon -- (Not Moderated) -- Started: 8/5/1996 8:27:00 PM  Revision History

Anyone follow this small biotech company. Its lead drug is Norcalcin for the treatment of HPT. Norcalcin is starting the second phase trials and mimicks the action of calcium by activating the calcium receptor. Recently Amgen has signed a 43.5 million dollar deal to develop and market the drug. Recently touted by George Southerland in his newsletter. Any comments apprriciated!
Previous 10 | Next 10 | View Recent | Post Message Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsDate
330With today's news of GATTEX meeting primary endpoints, the stock has hit a mtuck-01/31/2011 01:58 PM
329We are now looking at early 2012 for Gattex launch, with money sufficient only ttuck-04/14/2010 01:17 PM
328And the calcilytic whiffs: >>NPS Pharma says Glaxo stops osteoporosis drutuck-09/26/2008 01:21 AM
327>>NPS Reports Successful GATTEX(TM) Extension Study Monday March 17, 4:00 tuck-03/17/2008 04:19 PM
326>>Nycomed has decided to continue development of GATTEX, which is a big retuck-01/28/2008 04:41 PM
325Nycomed has decided to continue development of GATTEX, which is a big relief to tuck-10/31/2007 11:28 AM
324>>Clinical Benefits Demonstrated with Low-Dose GATTEX(TM) in Phase 3 Shorttuck-10/11/2007 09:31 AM
323>>NPS Sells Assets Related to mGluR Collaboration to AstraZeneca for $30 Mtuck-10/09/2007 02:38 PM
322MSTAR: We're placing NPS Pharmaceuticals NPSP under review as we digest a nmopgcw-09/28/2007 02:57 PM
321Tuck; Might have leaked early! Interesting discussion on Yahoo wondering why tSteve Lokness-09/27/2007 01:13 PM
320>>NPS Pharmaceuticals and Nycomed Announce Licensing Agreement for GATTEX(tuck-09/26/2007 10:15 AM
Previous 10 | Next 10 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
Copyright © 1995-2013 Knight Sac Media. All rights reserved.